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Tumour invasionThe interactions of cancer cells within a solid mass with the surrounding reactive stroma are critical for
growth and progression. The surrounding vasculature is recruited into the periphery of the growing
tumour to supply cancer cells with nutrients and O2. This study focuses on developing a novel three-
dimensional (3-D) in vitro biomimetic colorectal cancer model using colorectal cancer cells and connec-
tive tissue cells. The 3-D model comprises a dense artiﬁcial cancer mass, created by partial plastic com-
pression of collagen type I containing HT29 colorectal cancer cells, nested in a non-dense collagen type I
gel populated by ﬁbroblasts and/or endothelial cells. HT29 cells within the dense mass proliferate slower
than when cultured in a two-dimensional system. These cells form tumour spheroids which invade the
surrounding matrix, away from the hypoxic conditions in the core of the construct, measured using real
time O2 probes. This model is also characterized by the release of vascular endothelial growth factor
(VEGF) by HT29 cells, mainly at the invading edge of the artiﬁcial cancer mass. This characterization is
fundamental in establishing a reproducible, complex model that could be used to advance our under-
standing of cancer pathology and will facilitate therapeutic drug testing.
 2013 The Authors. Published by Elsevier Ltd. All rights reserved.1. Introduction
The ability to grow cancer cells in vitro has informed much of
our understanding of the biology of cancer. Its convenience and
accessibility have made it a distinct alternative in many cases to
in vivo animal experimentation. However, the simplicity of many
of the models has also been their downfall, as they tend to be
two-dimensional (2-D) and largely overlook host-related factors
as determinants of tumour progression [1]. What has been missing
is an in vitro model that has many of the known attributes of an
in vivo cancer growing within the host environment. Some of these
attributes are host related, while others are tumour related. Host-
related factors might include deﬁned three-dimensional (3-D)
compartments, a range of tissue tonicities, appropriate stromal ra-
tios (glycoproteins and proteoglycans) and relevant supporting
cells in terms of both type and proportion. The tumour-related
attributes necessary for a biomimetic model would ideally com-prise differential cell proliferation, central hypoxia, compartment
invasion and new vessel formation.
Most of the attempts to recapitulate these biomimetic proper-
ties have been achieved by shifting from 2-D culture studies to cul-
turing cancer cells in 3-D scaffolds. Examples include the creation
of multicellular tumour spheroids [2] and the generation of tumour
colonies grown in tissue engineered structures [3]. 3-D models
have, so far, been useful in furthering our understanding of many
tumour-related processes, such as invasion and responsiveness to
antitumour agents [4,5].
The 3-D models that have been described to date have incorpo-
rated a range of matrices, both natural and synthetic. The natural
constituents typically comprise a laminin-rich extracellular matrix
of collagen type I or hyaluronic acid [3,5]. Synthetic matrices in-
clude the use of polyethylene glycol (PEG), which is a biocompati-
ble and biodegradable polymer used for a variety of tissue
engineering applications. Synthetic matrices have the advantages
of being easily modiﬁed to enhance biomimetic function, including
the incorporation of bioactive peptides such as the integrin-bind-
ing motif RGD (Arg–Gly–Asp) [6], which can be achieved via ﬁbrin
stabilizing factor (factor XIII)-catalysed cross-linking [7], as well as
engineered polymers with speciﬁc matrix metalloproteinase
(MMP) sites for improved biodegradation [8]. Collagen type I
hydrogels have been used more recently, with markedly different
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production of angiogenic growth factors. A limiting factor of these
scaffolds is that they are mainly comprised of water, while to accu-
rately mimic a tumour much denser collagen scaffolds need to be
used [9].
As we engineer more biomimetic 3-D models we enhance our
understanding and overcome current limitations, such as the use
of cancer cell lines that form spheroids within a 3-D scaffold with-
out a distinct stromal component [1]. These models are used for
drug testing but are poor models for exploring innate tumour char-
acteristics, given the absence of interactions with the stroma [10–
13]. Most groups that have attempted to incorporate a cancer–
stromal cell mix (usually ﬁbroblasts) into a 3-D matrix [14] have
done so without trying to recreate the tissue architecture seen
in vivo. A recently described colorectal cancer model does place
cancer spheroids in a suspension of ﬁbroblasts housed in a collagen
matrix [15]. This attempted to create a more biomimetic spatial
conﬁguration of a tumour surrounded by a reactive stroma, and
this spatial mimicry resulted in a change in colorectal cancer cell
morphology. Such biomimetic 3-D in vitro models represent a dis-
tinct advance on the traditional 2-D constructs [16].
This paper describes our attempt to narrow the gap between
in vitro 3-D models and the in vivo scenario. Below we describe
the creation of a 3-D in vitro colorectal cancer model that is biomi-
metic from a structural and spatial perspective and has the attri-
butes of in vivo models. Validation of this model includes real
time hypoxia measurements within the growing tumour.
2. Materials and methods
2.1. Cell culture
HT29 human colon adenocarcinoma cells were used to create
the artiﬁcial cancer mass (ACM). For the surrounding tumour stro-
ma we used either the mouse embryonic ﬁbroblast cell line 3T3
(ECACC, Sigma-Aldrich, Poole, UK) or the human colon ﬁbroblast
cell line CF56, isolated from normal patient colon, as previously de-
scribed [17]. (Informed consent was obtained from patients prior
to surgery and the study was approved by the University College
Hospital Independent Ethics Committee.) Brieﬂy, primary human
ﬁbroblasts were isolated from areas of normal colon within a re-
sected specimen from a patient with Duke’s B stage colorectal ade-
nocarcinoma. Cells were extracted from macerated tissue adjacent
to, but not part of, the cancer tissue. Antibody-coated magnetic
beads were used to remove epithelial and endothelial cells; the
remaining cells (b-actin positive) were propagated in culture and
used between passages 4 and 12. Fibroblasts were used either
alone or together with the human umbilical endothelial cell line
HUVEC (ECACC). HT29, 3T3 and CF56 cells were cultured as 2-D
monolayers in low glucose Dulbecco’s modiﬁed Eagle’s medium
(DMEM) (1000 mg l1 glucose, Sigma-Aldrich) supplemented with
10 vol.% foetal bovine serum (FBS) (First Link UK, Wolverhampton,
UK), 100 U ml1 penicillin and 100 lg ml1 streptomycin (P/S)
(Invitrogen, Paisley, UK). HUVEC were cultured in enriched endo-
thelial cell growth medium (EECGM, PromoCell, Heidelberg, Ger-
many) containing endothelial cell medium supplement
(PromoCell), 10% FBS and P/S. Cells were cultured under aseptic
conditions in a humidiﬁed atmosphere with 5% CO2 at 37 C.
2.2. Engineering an in vitro biomimetic3-D cancer construct
ACMs were manufactured by seeding cancer cells in collagen
type I hydrogels and applying plastic compression to increase the
cell and matrix density. To prepare the collagen hydrogel contain-
ing HT29 cells collagen type I (rat tail collagen type I, 2.04 mg ml1
in 0.6% acetic acid, First Link UK) was mixed with 10 concen-trated minimum essential Eagle’s medium (MEM) (Invitrogen).
The solution was neutralized in a drop-wise manner, ﬁrst with
5 M and then 1 M NaOH, and assessed by a visible colour change
from yellow to bright pink, indicating a pH of 7.3. At this stage
the cancer cell suspension was added and the combination was
gently mixed using a Pasteur pipette. The volume ratios of collagen
type I:MEM:cell suspension were: 8:1:1. This cellular collagen
solution was thoroughly mixed and transferred to a mould, then
left to incubate for 30 min at room temperature, allowing the gel
to set. Typically 4 ml of HT29 cell–gel solution was used.
Once set, the density of the HT29-containing cellular collagen
gel (ACM) was increased by partial plastic compression [18]. The
mould containing the gel was placed on a 165 lm steel mesh
and a nylon mesh on absorbent paper. The gel was compressed un-
der a 73.55 g load for 20 s. The load was removed and the gel was
allowed to self-compress for a further 5 min. The gel was turned
over and the process repeated.
The collagen density was assessed by comparing the wet and
dry weights of the acellular gels that underwent none, partial or
full compression. For full compression the load was applied to
the gel for 5 min on both sides.
Partially compressed ACMs were cut into four pieces of approx-
imately 5.5  10 10mm using a sterile surgical blade. Two pieces
were transferred to opposite sides of a rectangular plastic mould
(75 25  15mm). The mould was ﬁlled with 10 ml of collagen
gel which was either acellular (collagen I:MEM ratio 9:1) or con-
tained cells (collagen I:MEM:cell suspension ratio 8:1:1). In order
to engineer a three cell type-containing gel, after the ACM was
placed in the mould 5 ml of collagen gel containing ﬁbroblasts
was ﬁrst added, followed by the addition of 5 ml of collagen gel con-
taining endothelial cells. The uncompressed cellular gels (containing
either ﬁbroblasts or endothelial cells) were neutralized to pH 7.3 be-
fore being added to the mould following the method described
above. A range of concentrations of ﬁbroblasts and endothelial cells
were tested (<2 106 cells ml1), with concentrations of 2.5 105 -
cells ml1 considered optimal. The whole process is schematically
represented in Fig. 1.
2.3. Cancer cell proliferation in two and three dimensions
HT29 proliferation was assessed by the Alamar Blue assay,
which measures chemical reduction of the dye, indicative of met-
abolic activity of mitochondrial enzymes, which is determined
from the ﬂuorescent signal at 570 nm. Partially compressed ACMs
(1 ml) were placed in 6-well plates, covered in fully supplemented
DMEM and incubated for up to 14 days. On days 1, 3, 5, 7 and 14
the medium was removed and 2 ml of 1:10 by volume Alamar Blue
solution (AbD Serotec, Kidlington, UK) in phenol-free DMEM (Sig-
ma-Aldrich) was added. Gels were incubated for 3 h at 37 C on
an orbital shaker at 4–5 g. Cell densities used for the ACM were
5  105, 1  106 and 2  106 cells ml1.
For 2-D culture cells were seeded in 6-well plates at 1  104 and
2  104 cells cm2 and maintained at 37 C in 5% CO2/air. Growth
was assessed at the same time points as for the 3-D cultures, by
Alamar Blue assay.
2.4. Cell morphology and migration within the 3-D cancer model
Cell morphology and migration in 3-D collagen constructs were
determined by light microscopy of haematoxylin and eosin (H&E)
stained sections. Constructs were ﬁxed for 2.5 h in 10% neutral buf-
fered formalin, processed in an automated tissue processor (Tis-
sue-TEK VIP, Sakura Fineterk, Torrance, CA) and embedded in
parafﬁn. Sections were cut at 10 lm and placed in an oven at
60 C overnight. Sections were rehydrated through xylene and
100%, 90% and 70% alcohol solutions, stained with haematoxylin
Fig. 1. Schematic demonstrating construction of the 3-D in vitro cancer model. (i) Formation of an ACM. Partial compression of the cancer cell populated collagen hydrogel to
increase the collagen and cell density. Division of the partially compressed ACM into appropriate ﬁnal units. (ii) Insertion of the ACM into acellular collagen hydrogel. (iii)
Insertion of the ACM into a cellular collagen hydrogel populated with ﬁbroblasts and/or endothelial cells.
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a further 5 min. Finally, sections were taken back through 70%, 90%
and 100% alcohol solutions and xylene and mounted in DPX moun-
tant (Sigma) for viewing.
2.5. Hypoxia
Oxygen levels were measured in 3-D constructs comprising the
ACM nested in acellular collagen using an Oxylite 4000 tissue oxy-
genation monitoring system (Oxford Optronix, Oxford, UK). A ﬁbre
optic probe was inserted into the 3-D construct either deep within
the ACM or at the ACM/‘‘stroma’’ interface (Fig. 2iv and v). Oxygen
levels were measured for up to 140 h in open cultures under rou-
tine conditions (Fig. 2iii–v). The tip of the sensor probe (280 lm
diameter) incorporates an oxygen-sensitive luminescent probe
within an oxygen permeable matrix, where the luminescence is
quenched in the presence of molecular oxygen, thus the emission
lifetime is longer at lower oxygen concentrations. Calibration of
the probe, which is accurate to 0.7 mmHg, is reliant on correlation
of the luminescence lifetime (rather than intensity) versus the oxy-
gen concentration [19]. This method results in a stable calibratedresponse such that each probe can be used for up to 7 days at
the slowest sampling rate. After each experiment the probe was
checked against the external medium to conﬁrm that there was
no drift in the response. The ﬁbre optic probes were used in con-
junction with an OxyLab pO2 E™ system coupled to an A/D con-
verter (12 bit) and the results were recorded on an IBM PC
computer using Labview. The results are presented as partial pres-
sure values, i.e. pO2 in mmHg (e.g. 7.6 mmHg corresponds to 1%).
In addition, hypoxia was veriﬁed by staining with pimonidazole,
according to the manufacturer’s instructions. Pimonidazole is acti-
vated and forms protein adducts in cells at oxygen partial pressures
<10 mmHg. Before ﬁxing the 3-D constructs were incubated for 2 h
in 100 lM pimonidazole hydrochloride (Hypoxyprobe™, Natural
Pharmacia International, Burlington, VT) with agitation at 37 C.
Constructs were ﬁxed and processed as standard. 4 lm sections
were peroxidized for 5 min in 3% H2O2 (Calbiochem Milipore, Wat-
ford, UK) and incubated for 20 min at 55 C in citrate buffer (pH 6).
Sections were washed in rinse buffer and incubated for 5 min in
blocking buffer (1% bovine serum albumin (BSA) in Tris-buffered
saline (TBS)). After further washing the primary antibody ﬂuores-
cein isothiocyanate (FITC)-labelled MAb1 (1:50 in primary antibody
Fig. 2. Characteristics of the collagen type I gel and ACM. (i) Collagen density of the acellular gel after partial and full compression. (ii) Growth rate of HT29 cells in 3-D
collagen gels and on cell culture plates (2-D) obtained from the metabolic activity measured by Alamar Blue assay. (iii) Representation of the 3-D tumour model with inserted
optic ﬁbre probe measuring the oxygen level (light), (iv, v) Oxygen levels in the ACM populated with HT29 and surrounded by acellular collagen type I measured by tissue
oxygenation monitoring: (iv) oxygen level in the core of the ACM and (v) oxygen level at the interface between the ACM and surrounding gel.
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Sections were washed and incubated with secondary rabbit anti-
FITC IgG (1:50 in phosphate-buffered saline (PBS)) for 30 min at
room temperature. Sections were then peroxidized for 10 min in
3,30-diaminobenzidine (DAB), washed in distilled water and rinse
buffer and counterstained with haematoxylin for 1 min. Dehydrated
samples were mounted with DPX and assessed under a light micro-
scope (Optika, Italy) using digital imaging system Inﬁnity 2 (Digital
Imaging Systems, Bourne End, UK).
2.6. VEGF production
Indirect immunoﬂuorescent staining was performed to investi-
gate the presence of VEGF. 4 lm sections (prepared as above) were
microwaved in citrate buffer (pH 6) at 800W, followed by three
10 min washes in PBS. Sections were treated with permeabilizationsolution (Millipore, Watford, UK) for 15min and blocking buffer for
a further 15min. Slides were incubated with rabbit polyclonal anti-
VEGF (Santa Cruz Biotechnology, Santa Cruz, CA) overnight at 4 C in
a humidiﬁed chamber. Both antibodies were diluted 1:50 in primary
antibody diluent (Abcam). Sections were then washed three times in
PBS and incubated with goat Alexa Fluor 546-labelled anti-rabbit
antibody (orange ﬂuorescence, 1:100 in PBS) for 2 h in the dark at
room temperature. After incubation the sections were washed in
PBS (3  10min) and mounted in Vectashield/DAPI. Slides were as-
sessed using a ﬂuorescence microscope (Olympus BX61, Southend-
on-Sea, UK) using CellF ﬂuorescence imaging software (Olympus).
2.7. Statistical analysis
The data were parametric and treated by one-way ANOVA fol-
lowed by post hoc analysis.
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3.1. Collagen density
Partial plastic compression of acellular collagen I hydrogels re-
sulted in a six times increase in collagen density to 12 mgml1
(2.6%). The surrounding collagen hydrogel remained uncompressed
with a collagen density of 2.04 mgml1 (0.25%). Complete or full
compression of acellular hydrogels resulted in a 16 times increase,
giving a collagen concentration of 33mgml1 (7.2%) (Fig. 2i).
3.2. Cancer cell proliferation in 3-D
Proliferation of HT29 cells was assessed in both 2-D and 3-D.
HT29 were seeded in a partially compressed collagen I gel (initial
cell densities 5  105, 1  106 and 2  106 cells ml1) or grown
on a tissue culture plate (cell densities 1  104 and 2  104
cells cm2). Growth was assessed by Alamar Blue assay.
The rate of growth was similar for cells in both 2-D and 3-D cul-
tures up to day 2. Between 3 and 14 days 2-D cultured cells contin-
ued growing in an exponential fashion, while 3-D cultures were
considerably slower, following a steady rate of growth (Fig. 2ii).
From repeat experiments over a wider range of HT29 cell densities
for ACM construction the optimal density was determined to be
1.6  106 cells ml1, and this was used in experiments incorporat-
ing further cell types described below.
3.3. Cell morphology and migration in the 3-D cancer model
3-D constructs were engineered at different levels of complex-
ity. The simplest constructs were designed with ACMs containingFig. 3. Morphology of HT29 colorectal cancer cells (2,000,000 cells ml1) in an ACM situa
an equal distribution of cells within the ACM; (ii) day 7 showing accumulation of cells at
(green arrows) and migration into the surrounding matrix (black arrows); (iv) day 21 sh
bar 400 lm.two different seeded HT29 cell densities, either 5  105 or 2  106 -
cells/ml, nested in non-compressed acellular collagen I gels. These
were cultured for up to 21 days. Within 24 h HT29 cancer cells
were observed to be evenly spread throughout the dense collagen
of the ACM (Fig. 3i). Within 7 days cell spheroids were formed
within the ACM (Fig. 3ii), which appeared to move to the edge of
the dense ACM and to migrate into the non-dense surrounding col-
lagen by 14 days (Fig. 3iii). This migration of cell spheroids into the
surrounding uncompressed collagen was observed up until day 21
(Fig. 3iv). The more complex 3-D constructs incorporated more cell
types (ﬁbroblasts and/or endothelial cells) within the non-com-
pressed collagen hydrogel surrounding the ACM. Addition of 3T3
(or CF56) ﬁbroblasts to the surrounding matrix induced a decrease
in the volume of the whole collagen construct, due to ﬁbroblast-
generated collagen contraction, a known phenomenon in collagen
hydrogels [20,21]. The addition of 3T3 ﬁbroblasts also appeared to
result in a decrease in the proliferation rate of cancer cells within
the ACM. Spheroids/cancer foci on day 21 were smaller in more
complex constructs with cellular stromal surrounds, and averaged
45 lm (. 4iii), compared with those with acellular stromal sur-
rounds, where the spheroid size was found to be three times as
large at 145 lm (p < 0.001) (Figs. 3iv and 4v). 3T3 ﬁbroblasts
showed migration towards the outer edge of the construct from
day 1, with ﬁbroblast multilayers observed by day 14 (Fig. 4i and
ii). Interestingly, when endothelial cells (HUVECs) were added to
the surrounding collagen together with 3T3 cells limited contrac-
tion of the collagen hydrogel was observed, suggesting partial
opposition to the contraction induced by 3T3 cells alone. Non-can-
cer cells situated in the surrounding uncompressed collagen
hydrogel migrated in two directions, towards the outer edge of
the construct and also towards the ACM. The contraction eventsted within an uncompressed acellular collagen gel (H&E staining). (i) Day 1 showing
the edge of the ACM (blue arrows); (iii) day 14 showing formation of cell spheroids
owing escape of the cell spheroids into the surrounding matrix (black arrow). Scale
Fig. 4. Morphology of HT29 colorectal cancer cells (500,000 cells ml1) in an ACM situated within a collagen gel. (i, ii) The surrounding collagen was populated by 3T3 cells
(blue arrow, 250 000 cells ml1) and H&E staining was performed on day 14. (iii–v) The surrounding collagen was also populated by 3T3 cells together with HUVEC (250
000 cells ml1) and H&E staining was performed on day 21, showing HT29 cell spheroids (green arrows) with sizes smaller than in Fig. 3 and detachment of the ACM from the
surrounding matrix (by 150 lm) lined by 3T3 cells (blue arrow) and HUVEC (red arrow) into the surrounding matrix. Scale bars: black, 400 lm; blue, 200 lm; red, 100 lm.
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rounding collagen I matrix, as demonstrated on day 21 in the 3-
D constructs (Fig. 4iii and v). Separation of the dense ACM could
be also affected by collagen processing for histological analysis.
3.4. Hypoxia within the 3-D cancer model
Oxygen levels were monitored in the 3-D constructs using ﬁbre
optic probes, within the ACM core and at the interface of the ACM
and the surrounding uncompressed acellular collagen, for up to
6 days. Oxygen levels within the ACM showed a dramatic drop
from 125 to around 10 mmHg within the ﬁrst 4–5 h. The oxygen
level then ﬂuctuated between 2 and 10 mmHg (0.3–1.3% oxygen)
over the following 112 h (Fig. 2iv). This level is considered equiva-
lent to pathological hypoxia. The oxygen tension at the boundary
between the ACM and uncompressed collagen was characterized
by a slower drop from 130 to around 70 mmHg in the ﬁrst 4 h. It
was followed by a steady gradual drop to around 20 mmHg in
the next 100 h, which reached around 5 mmHg at 134 h (Fig. 2v).
Hypoxia within the ACM was conﬁrmed by positive staining
with pimonidazole (HT29 concentration 1.6  106 cells ml1). Thiswas evident in the ACM on days 7 and 14, with no positive staining
in the outside non-dense gel populated by CF56 cells and HUVEC
(both at a density of 2.5  105 cells ml1) (Fig. 5i).3.5. Angiogenic response in the 3-D cancer model: VEGF production
VEGF expression was determined by immunoﬂuorescence. Posi-
tive staining was observed in cancer cells throughout the ACM
(surrounded by acellular collagen) from day 7. On days 14
(Fig. 5ii) and 21 (Fig. 5iii) VEGF expression was clearly evident in
cancer cell spheroids/foci.
Production of VEGF was greater in cultures where the ACM was
surrounded by a cellular hydrogel (3T3 without or with HUVEC).4. Discussion
4.1. Summary of results
We have created a 3-D cancer model from HT29 cell lines char-
acterized by a dense artiﬁcial cancer mass surrounded by a non-
Fig. 5. Immunostaining for hypoxia and VEGF release in ACM surrounded by acellular gel. (i) Hypoxia was conﬁrmed by positive binding of antibody (brown) against
pimonidazole, an exogenous hypoxia marker, and can be observed on day 14. Scale bar: black 1 mm; red, 200 lm. (ii, iii) VEGF release was conﬁrmed by anti-VEGF staining
(red), with DAPI counterstaining (blue) on (ii) day 14 and (iii) day 21. Scale bars correspond to 1 mm and 200 lm for the main display and higher magniﬁcation, respectively.
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oid size was directly related to whether or not the surrounding
stromal environment was acellular or populated with cells. The
additional biomimetic properties of the ACM permitted multidirec-
tional migration and growth into the surrounding ‘‘stromal’’ com-
ponent. Hypoxia within the tumour was also demonstrated, and
conﬁrmation of VEGF expression by cancer cells was considered
a marker of the initiation of angiogenesis.
4.2. Methodological considerations
The 3-D tumour model comprised distinct regions, in terms of
both the cell composition and collagen density, in a conﬁguration
which was spatially relevant to solid tumour growth in a tissue.
Integration of the two components, which differed signiﬁcantly
in their collagen composition, was difﬁcult in early cultures. By
optimizing cell densities we were able to, in part, overcome this
challenge of integration by ensuring the outer collagen hydrogel,
stroma equivalent, contained enough cells to re-model the matrix.Accurate real time O2 measurements in tumours in vivo are a
challenge, but it is well documented that the hypoxic core of tu-
mours quickly becomes necrotic due to the lack of an oxygen sup-
ply. Using probes to measure and assess O2 tension in our ACM and
the surrounding ‘‘stroma’’ we were able to draw comparisons with
the tumour scenario in vivo. In future these measurements will be
used to assess tumour growth and invasion in this model.
The HT29 cell line is a spontaneously immortalized colorectal
adenocarcinoma line, widely used in laboratory modelling. Its de-
scribed mutations, e.g. P53, are relevant to colorectal oncogenesis
and it exhibits moderate differentiation (glandular organization)
and invasion in in vivo models. Invasion by HT29 cells from the
ACM into the surrounding matrix (both acellular and cellular)
was assessed using histology. The observed features included
approximate glandular formation by cancer cells concentrated at
the outer edges of the ACM, which often appeared to break away
from the main ACM body and invade the surrounding hydrogel.
This picture is very similar to that found in human biopsies of colo-
rectal cancer.
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Advances have been made in increasing the density of biomi-
metic collagen scaffolds in a controlled manner. These processes
include increasing the concentration of collagen in acid solution
and/or the physical expulsion of excess ﬂuid by means of compres-
sion. In contrast, methods that have been used to increase the con-
centration of collagen rely principally upon techniques that
promote evaporation [22]. Other methods that have been reported
include reverse dialysis [23], continuous injection of low concen-
tration collagen solutions into glass microchambers [24], or a com-
bination of the two [25]. These methods have a limitation on the
volumes produced (reverse dialysis) and the formation of concen-
tration gradients (injection method).
The application of a controlled load to plastically compress (PC)
standard collagen hydrogels to expel excess ﬂuid and increase the
collagen density has become particularly useful in the ﬁeld of tis-
sue engineering [18]. Applications of this PC technology are useful
for in vitro tissue modelling, as cell viability is retained in cells
embedded within scaffolds undergoing PC, and the density in-
crease (both for matrix and cells) is controllable and results in
higher biomimetic densities. Using partial plastic compression
we increased collagen densities by up to 10 times. We now aim
to further our progress in this area by engineering ACM densities
of 8–11% and even higher. The goal of biomimetic tissue engineer-
ing is to control the scaffold architecture such that it is truly biomi-
metic, we therefore believe that engineering the density is a critical
ﬁrst step.
4.4. Comparison with other studies
Our manipulation of collagen density using PC is the ﬁrst use of
this technology for 3-D tumour culture. It allowed us, in part, to
culture cells at a more biomimetic tissue density. We controlled
collagen density using a partial plastic compression method, which
resulted in a ﬁnal collagen percentage of up to 4% [26]. This high
density collagen was surrounded by a non-compressed gel (0.25%
collagen concentration). The use of intact native, ﬁbrillar collagen
as a 3-D matrix in which to grow cells is hugely beneﬁcial in mim-
icking the native cell–matrix interactions found in vivo. Cell–ma-
trix interactions are known to affect cell proliferation,
differentiation and cell signalling [27]. Use of the plastic compres-
sion method conserved the ﬁbrillar collagen structure and in-
creased the collagen density to that approaching the levels found
in vivo, with limited loss of viability [18]. Applying the plastic com-
pression technique we have engineered dense tumour masses
which are biomimetic.
Growth rates of HT29 cancer cells in our 3-D model were in line
with the growth rates seen in vivo. After 7 days the HT29 cells dis-
played signiﬁcantly lower growth rates than those seen in 2-D cul-
tures. This differential growth pattern has been previously
described. Glioma cell lines cultured in Matrigel and chitosan scaf-
folds exhibited slower growth rates than those seen in 2-D systems
[28]. The slower growth rates seen in 3-D models more closely
resemble those seen in vivo, as a consequence of the restraints on
energy availability within a solid structure and its given surface area.
Our model structure allowed us to observe aspects of growth
and migration hitherto not reported in other systems. The initia-
tion of formation of HT29 spheroids was seen on day 7. By day
14 these spheroids had migrated outside the ACM into the non-
compressed surrounding hydrogel. The stiffness of the matrix
inﬂuences the formation of spheroids [7]. Softer PEG hydrogels
(1.5%) tend to form more irregular and scattered spheroids.
Increasing the density of the hydrogel (2.5%) forces the creation
of more compact and dense spheroids, once again mimicking what
we ﬁnd in vivo. The mechanism for this is likely to involve changesin integrin binding sites, which, in turn, promote focal adhesion
assembly leading to increased growth factor-dependent ERK acti-
vation [29].
The other novel attributes of our system relate to the incorpora-
tion of ﬁbroblasts in the non-dense collagen gel surrounding the
ACM, mimicking the natural tumour stroma. Fibroblast seeding
caused collagen matrix contraction and, thus, a decrease in the vol-
ume of the collagen construct within the ﬁrst 3 days. A similar phe-
nomenon was observed when ﬁbroblasts were co-cultured with
human breast tumour spheroids in a collagen type I gel [14]. This
ﬁbroblast-mediated contraction of the whole system further inhib-
ited the access of cancer cells in the ACM to both nutrients and
oxygen. This effect may further serve to align growth rates to those
observed in vivo. The mechanism by which this occurs is known
[30]: ﬁbroblasts release proteinases, such as MMPs, that degrade
collagen and disrupt the formation of co-units by other cells. One
of the most exciting ﬁndings from this model has been the depen-
dence of spheroid size on the stromal component (Fig. 4). Where
cells are present in the stromal component the spheroid size was
limited, in fact three times smaller than when no cells were pres-
ent in the stromal surround. It is likely that paracrine signalling by
stromal cells limits spheroid size. Cell–cell interactions between a
cancer mass and the surrounding stroma inﬂuence tumour growth
and metastasis, and it is intriguing to see this recapitulated in our
biomimetic model. Further analysis is necessary to understand this
interaction, but this model provides an ideal platform for research
in this area.
Contraction of the system was limited by the addition of endo-
thelial cells to the ﬁbroblasts-seeded stromal component. On day
21 these stromal cells were found not only on the outside edge
of the construct but also in close proximity to the ACM. However,
the ACM started to detach from the surrounding collagen, which
could be caused by the proteinases released by surrounding cells.
We are currently investigating why the ﬁbroblasts essentially go
one of two ways: a portion of the ﬁbroblasts appears to be at-
tracted to the ACM, while the other migrates towards the outer
edge, towards the highest oxygen and nutrient levels. The detach-
ing ACM was also characterized by the presence of tumour spher-
oids. These morphological changes in cancer cells indicate their
potential invasiveness by forming spheroids that migrate into dif-
ferent regions of the system.
The incorporation and measurable tracking of hypoxia within
our 3-D system is novel. Hypoxia is one of the important drivers
of tumour growth. Our system was associated with oxygen deple-
tion in the core from 125–130 to around 10 mmHg within the ﬁrst
4 h. The changes at the outer edge of the ACMwere less dramatic in
both rate and degree. Within the ﬁrst 10 h oxygen levels dropped
to below 60 mmHg, and after 90 min to around 20 mmHg. Pimon-
idazole staining conﬁrmed the hypoxic regions at the edges of the
ACM, to which most cancers cells had migrated. Other groups have
documented hypoxia using pimonidazole staining in multicellular
spheroids cultured in nano-imprinted cyclooleﬁn resinous scaf-
folds [31].
The effect of hypoxia on tumour-initiated angiogenesis was
seen in our model. Positive VEGF immunoﬂuorescence staining
was seen in ACM on days 7, 14 and 21. On day 7 VEGF was found
throughout the ACM, however, from day 14 its release was mainly
found around newly formed tumour spheroids. In the model incor-
porating both ﬁbroblasts and endothelial cells VEGF release was
observed within the ﬁrst 24 h. Moreover, it was present in both
ACM and the surrounding collagen. This conﬁrms that VEGF was
released by both the growing tumour cells and the surrounding
supporting cells. VEGF production by the stromal cells also indi-
cates that the ﬁbroblasts and endothelial cells were in a hypoxic
environment, probably created by cell consumption of oxygen
within this stromal compartment.
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Having a 3-D model with biomimetic properties raises new and
important possibilities.
Firstly, a model which closely approximates our current under-
standing of the spatial and architectural nature of tumours pro-
vides us with a platform to further our understanding of the
importance and implications of these interdependent structures.
The tumour–stromal interactions that we have documented concur
closely with those described in vivo.
The second point relates to developing novel therapies, whether
they are physical or chemical. When these 3-D models exhibit hy-
poxia gradients they may be used to reﬁne new radiotherapy tech-
niques, given that hypoxia is the greatest impediment to successful
radiotherapy. Chemotherapeutic agents and biological modifying
agents could be assessed during the early target veriﬁcation phase
in a more meaningful manner with the 3-D models that we have
described, as they are much closer to the real targets that they
are seeking to modify. The complexity of the 3-D in vitro models
will allow the mechanisms by which novel therapies may work
to be explored.
Third, 3-D models give the opportunity to gain an insight into
the way in which tumours are currently imaged in clinical practice.
Multiparametric magnetic resonance imaging uses sequences that
measure cell density by virtue of the Brownian motion of protons
within the cancer cells and within the extracellular space. These
indicate the diffusion sequences and are becoming the mainstay
of cancer diagnosis and monitoring in most organ systems. Our
3-D model is amenable to sequential imaging, a process that will
allow us to understand the biological changes that trigger these
different signals.
Fourth, we have described the basis of a platform technology
that can be designed for the task in hand. A number of different tu-
mour types could be embedded in a number of constructs that con-
form to different speciﬁcations, in terms of both the stroma and the
nature and proportion of the supporting cells. Although we have
not described it here, energy and nutrient availability can also be
controlled in line with standard tissue engineering techniques.4.6. Future directions
We believe that our 3-D in vitro tumour model provides a plat-
form on which complexity can be bestowed. We have documented
some of these complex parameters, including various cell types,
matrix densities, tumour hypoxia and angiogenic response. There
exists, however, considerable scope to improve upon this early
work. We would encourage other groups to exploit their areas of
expertise in other tumour types and/or other associated supporting
cells to further reduce the gap between the events that we see
within in vitro models of cancer and those that occur in vivo.5. Conclusions
Our use of tissue engineering principles has allowed us to create
a biomimetic model of malignant tumour and stroma with many of
the key in vivo attributes. The unique and important attributes of
our model include a dense ACM containing cancer epithelial cells
surrounded by a non-dense collagen hydrogel containing ﬁbro-
blasts and endothelial cells, mimicking the reactive stroma. This
arrangement has conferred on our model oxygen depletion within
the ACM, resulting in hypoxia and the production of VEGF. These
two attributes of cancer biology are fertile areas for future thera-
pies. Our model is likely to assist in the understanding of these pro-
cesses, andmay provide a useful model in which putative therapies
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search Centre, London, UK.Appendix A. Figures with essential colour discrimination
Certain ﬁgures in this article, particularly Figs. 1–5, are difﬁcult
to interpret in black and white. The full colour images can be found
in the on-line version, at http://dx.doi.org/10.1016/
j.actbio.2013.04.028.References
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